{
    "nctId": "NCT01008514",
    "briefTitle": "Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast Cancer",
    "officialTitle": "A Single Institution, Prospective, Non-randomized Study of Partial Breast Irradiation Using the MammoSite Radiation Therapy System (Breast Brachytherapy Applicator)",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Proportion of local recurrence",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically confirmed ductal carcinoma in situ (DCIS) of the breast or invasive breast adenocarcinoma\n\n  * Stage 0, I, or II (T2, N0; tumor size \u2264 3 cm) disease\n  * Pathologic staging of the axilla preferred\n\n    * Clinical staging of the axilla allowed for patients \u2265 70 years of age with hormone receptor-positive tumors\n* Unicentric tumor\n\n  * Microscopic multifocality allowed as long as the total tumor size is \u2264 3 cm\n* Must have undergone lumpectomy as definitive surgery\n\n  * Negative surgical margins, defined as no tumor at the inked margin of resection after final surgery\n\n    * Re-excision to obtain negative margins allowed\n* Must have adequate skin spacing between balloon surface and surface of the skin and lung (\u2265 7 mm)\n* No multicentric carcinoma (invasive or DCIS) in more than one quadrant\n* No clinically or pathologically positive regional lymph nodes\n* No extensive intraductal component, defined as DCIS extending beyond the primary invasive component into normal breast parenchyma and composing \\> 25% of the primary tumor\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Menopausal status not specified\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n* No collagen-vascular disease, including any of the following:\n\n  * Dermatomyositis\n  * Systemic lupus erythematosus\n  * Scleroderma-mixed connective tissue disease\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}